Skip to main content Accessibility help
×
Home
  • Print publication year: 2020
  • Online publication date: August 2020

Chapter 22 - Botanical Treatments for Medication-Resistant Epilepsy

Summary

Botanical treatments have been used by persons with epilepsy, especially for convulsive seizures, dating from 6000 BC in India [1], from 3000 BC in China and in Peru, and for centuries in Africa and South America. In traditional Western medicine, botanical treatments were widely used to treat seizures before the advent of compounds such as bromide and phenobarbital. For instance, Gowers documented his use of Cannabis indica (see also section on Cannabis and its Derivatives) and digitalis, the latter derived from the Foxglove plant (Digitalis purpurea) [2].

1.Jain, S. Ayurveda: the ancient Indian system of medicine. In: Devinsky, O, Schachter, S, Pacia, S (eds.), Complementary and Alternative Therapies for Epilepsy. New York: Demos Medical Publishing, 2005:123128
2.Gowers, WR. Epilepsy and Other Chronic Convulsive Diseases: Their Causes, Symptoms, & Treatment. London: Churchill, 1881:264268, 271
3.Sucher, NJ, Carles, MC. A pharmacological basis of herbal medicines for epilepsy. Epilepsy Behav 2015;52(Part B):308318
4.Samuels, N, Finkelstein, Y, Singer, SR, Oberbaum, M. Herbal medicine and epilepsy: proconvulsive effects and interactions with antiepileptic drugs. Epilepsia 2008;49:373380
5.Mbuba, CK, Ngugi, AK, Newton, CR, Carter, JA. The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia 2008;49:14911503
6.Ngugi, AK, Bottomley, C, Kleinschmidt, I, Sander, JW, Newton, CR. Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia 2010;51:883890
7.Lai, CW, Lai, YH. History of epilepsy in Chinese traditional medicine. Epilepsia 1991;32:299302
8.Xiao, F, Yan, B, Chen, L, Zhou, D. Review of the use of botanicals for epilepsy in complementary medical systems: traditional Chinese medicine. Epilepsy Behav. 2015;52(Part B):281289
9.Sriranjini, SJ, Sandhya, K, Mamta, VS. Ayurveda and botanical drugs for epilepsy: current evidence and future prospects. Epilepsy Behav. 2015;52(Part B):290296
10.Wahner-Roedler, DL, Elkin, PL, Vincent, A, et al. Use of complementary and alternative medical therapies by patients referred to a fibromyalgia treatment program at a tertiary care center. Mayo Clin Proc 2005;80:5560
11.Schachter, SC Herbs and botanicals. In: Rho, JM, Sankar, R, Strafstrom, CE (eds.) Epilepsy: Mechanisms, Models, and Translational Perspectives. Boca Raton, FL: CRC Press. 2010:403411
12.Lai, CW, Huang, X, Lai, YHC, et al. A survey of public awareness, understanding and attitudes toward epilepsy in Henan Province, China. Epilepsia 1990;31:182187
13.Hong, Z, Qu, B, Wu, X-T, et al. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China. Epilepsia 2009;50:21922198
14.Hu, J, Si, Y, Zhou, D, et al. Prevalence and treatment gap of active convulsive epilepsy: a large community-based survey in rural West China. Seizure 2014;23:333337
15.Danesi, MA, Adetunji, JB. Use of alternative medicine by patients with epilepsy: a survey of 265 epileptic patients in a developing country. Epilepsia 1994;35:344351
16.Govindaraghavan, S, Sucher, NJ. Quality assessment of medicinal herbs and their extracts: criteria and prerequisites for consistent safety and efficacy of herbal medicines. Epilepsy Behav 2015;52(Part B):363371
17.Liu, FX, Salmon, JW. Herbal medicine regulation in China, Germany and the United States. Integr Med 2010;9:5461
18.Blumenthal, M, Busse, WR. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines: Developed by a Special Expert Committee of the German Federal Institute for Drugs and Medical Devices. Austin, TX: American Botanical Council.1998.
19.Hoffman, FA. Botanicals as ‘new’ drugs: US development. Epilepsy Behav 2015;52(Part B):338343
20.Ekstein, D. Issues and promise in clinical studies of botanicals with anticonvulsant potential. Epilepsy Behav 2015;52(Part B):329332
21.Luciano, DJ, Spinella, M. Herbal treatment of epilepsy: phytotherapy. In: Devinsky, O, Schachter, S, Pacia, S (eds.) Complementary and Alternative Therapies for Epilepsy, New York: Demos Medical Publishing. 2005:143155
22.Delgoda, R, Westlake, AC. Herbal interactions involving cytochrome p450 enzymes: a mini review. Toxicol Rev 2004;23:239249
23.Li, Q, Chen, X, He, L, Zhou, D. Traditional Chinese medicine for epilepsy. Cochrane Database Syst Rev 2009;(3):CD006454
24.He, L, Wen, T, Yan, S, et al. Reevaluation of the effect of Dianxianning on seizure rate of refractory epilepsy as additive treatment in clinical practice. Front Med 2011;5:229234
25.Maa, E, Figi, P. The case for medical marijuana in epilepsy. Epilepsia 2014;55:783786
26.Porter, BE, Jacobson, C. Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy Behav 2013;29:574577
27.Hussain, SA, Zhou, R, Jacobson, C, et al. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: a potential role for infantile spasms and Lennox–Gastaut syndrome. Epilepsy Behav 2015;47:138141
28.Reddy, DS, Golub, V. The pharmacological basis of cannabis therapy for epilepsy. J Pharmacol Exp Ther 2016;357(1):4555
29.Rosenberg, EC, Tsien, RW, Whalley, BJ, Devinsky, O. Cannabinoids and epilepsy. Neurotherapeutics 2015;12:747768
30.Devinsky, O, Cilio, MR, Cross, H, et al. Cannabidiol: pharmacology and potential role in epilepsy and other neuropsychiatric disorders. Epilepsia 2014;55:791802
31.Gloss, D, Vickrey, B. Cannabinoids for epilepsy. Cochrane Database Syst Rev 2014;(3):CD009270
32.Szaflarski, JP, Bebin, EM. Cannabis, cannabidiol, and epilepsy: from receptors to clinical response. Epilepsy Behav 2014;41:277282
33.Thiele, EA, Marsh, E, French, JA, et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomized, double-blind, placebo-controlled phase 3 trial. Lancet 2018;391:10851096
34.Devinsky, O, Patel, AD, Cross, JH, et al. Effect of cannabidiol on drop seizures in the Lennox–Gastaut syndrome. N Engl J Med 2018;378:18881897
35.Devinsky, O, Cross, JH, Laux, L, et al. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med 2017;376:20112020
36.Schachter, SC. Botanicals and herbs: a traditional approach to treating epilepsy. Neurotherapeutics 2009;6:415420
37.Elsas, SM. A model on how to obtain data from botanical practitioners. Epilepsy Behav 2015;52(Part B):333337
38.Schachter, SC. Herbal therapies for epilepsy. In: Schwartzkroin, PA (ed.) Encyclopedia of Basic Epilepsy Research. Oxford: Academic Press.2009:14501454